• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四年后重复进行心血管风险评估:风险预测是否有所改善?

Repeat Cardiovascular Risk Assessment after Four Years: Is There Improvement in Risk Prediction?

作者信息

Chamnan Parinya, Simmons Rebecca K, Sharp Stephen J, Khaw Kay-Tee, Wareham Nicholas J, Griffin Simon J

机构信息

MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.

Cardio-Metabolic Research Group, Department of Social Medicine, Sanpasitthiprasong Hospital, Ubon Ratchathani, Thailand.

出版信息

PLoS One. 2016 Feb 19;11(2):e0147417. doi: 10.1371/journal.pone.0147417. eCollection 2016.

DOI:10.1371/journal.pone.0147417
PMID:26895071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4760966/
Abstract

BACKGROUND

Framingham risk equations are widely used to predict cardiovascular disease based on health information from a single time point. Little is known regarding use of information from repeat risk assessments and temporal change in estimated cardiovascular risk for prediction of future cardiovascular events. This study was aimed to compare the discrimination and risk reclassification of approaches using estimated cardiovascular risk at single and repeat risk assessments.

METHODS

Using data on 12,197 individuals enrolled in EPIC-Norfolk cohort, with 12 years of follow-up, we examined rates of cardiovascular events by levels of estimated absolute risk (Framingham risk score) at the first and second health examination four years later. We calculated the area under the receiver operating characteristic curve (aROC) and risk reclassification, comparing approaches using information from single and repeat risk assessments (i.e., estimated risk at different time points).

RESULTS

The mean Framingham risk score increased from 15.5% to 17.5% over a mean of 3.7 years from the first to second health examination. Individuals with high estimated risk (≥20%) at both health examinations had considerably higher rates of cardiovascular events than those who remained in the lowest risk category (<10%) in both health examinations (34.0 [95%CI 31.7-36.6] and 2.7 [2.2-3.3] per 1,000 person-years respectively). Using information from the most up-to-date risk assessment resulted in a small non-significant change in risk classification over the previous risk assessment (net reclassification improvement of -4.8%, p>0.05). Using information from both risk assessments slightly improved discrimination compared to information from a single risk assessment (aROC 0.76 and 0.75 respectively, p<0.001).

CONCLUSIONS

Using information from repeat risk assessments over a period of four years modestly improved prediction, compared to using data from a single risk assessment. However, this approach did not improve risk classification.

摘要

背景

弗雷明汉风险方程广泛用于基于单个时间点的健康信息预测心血管疾病。关于重复风险评估信息的使用以及估计心血管风险的时间变化对未来心血管事件预测的了解甚少。本研究旨在比较在单次和重复风险评估中使用估计心血管风险的方法的辨别力和风险重新分类情况。

方法

利用参与EPIC - 诺福克队列研究的12197名个体的数据,进行了12年的随访,我们在首次健康检查以及四年后的第二次健康检查时,按估计绝对风险水平(弗雷明汉风险评分)检查了心血管事件发生率。我们计算了受试者工作特征曲线下面积(aROC)和风险重新分类,比较了使用单次和重复风险评估信息(即不同时间点的估计风险)的方法。

结果

从首次健康检查到第二次健康检查,平均3.7年期间,弗雷明汉风险评分均值从15.5%升至17.5%。两次健康检查时估计风险均高(≥20%)的个体,其心血管事件发生率比两次健康检查时均处于最低风险类别(<10%)的个体高得多(分别为每1000人年34.0 [95%CI 31.7 - 36.6] 和2.7 [2.2 - 3.3])。与前一次风险评估相比,使用最新风险评估信息导致风险分类有微小的无显著变化(净重新分类改善为 - 4.8%,p>0.05)。与单次风险评估信息相比,使用两次风险评估信息可使辨别力略有提高(aROC分别为0.76和0.75,p<0.001)。

结论

与使用单次风险评估数据相比,在四年期间使用重复风险评估信息可适度改善预测。然而,这种方法并未改善风险分类。

相似文献

1
Repeat Cardiovascular Risk Assessment after Four Years: Is There Improvement in Risk Prediction?四年后重复进行心血管风险评估:风险预测是否有所改善?
PLoS One. 2016 Feb 19;11(2):e0147417. doi: 10.1371/journal.pone.0147417. eCollection 2016.
2
Change in HbA1c over 3 years does not improve the prediction of cardiovascular disease over and above HbA1c measured at a single time point.在 3 年内 HbA1c 的变化并不能提高单次测量 HbA1c 对心血管疾病的预测能力。
Diabetologia. 2013 May;56(5):1004-11. doi: 10.1007/s00125-013-2854-8. Epub 2013 Feb 12.
3
Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?在欧洲癌症与营养前瞻性调查-诺福克队列中对弗雷明汉风险评分的评估:添加糖化血红蛋白是否能改善冠心病事件的预测?
Arch Intern Med. 2008 Jun 9;168(11):1209-16. doi: 10.1001/archinte.168.11.1209.
4
5
Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.新西兰不同种族的弗雷明汉心血管风险评分表现:PREDICT CVD - 10。
N Z Med J. 2010 Feb 19;123(1309):50-61.
6
Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models.长期累积血压在心血管风险预测模型中的应用。
JAMA Cardiol. 2018 Nov 1;3(11):1096-1100. doi: 10.1001/jamacardio.2018.2763.
7
A simple risk score using routine data for predicting cardiovascular disease in primary care.基于常规数据的简单风险评分模型用于预测初级保健中的心血管疾病。
Br J Gen Pract. 2010 Aug;60(577):e327-34. doi: 10.3399/bjgp10X515098.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.弗雷明汉风险评分预测心血管疾病:来自南欧的基于人群的研究。
PLoS One. 2013 Sep 5;8(9):e73529. doi: 10.1371/journal.pone.0073529. eCollection 2013.
10
Standardization of the Fried frailty phenotype improves cardiovascular disease risk discrimination.标准化的 Fried 衰弱表型可改善心血管疾病风险的判别。
Exp Gerontol. 2019 May;119:40-44. doi: 10.1016/j.exger.2019.01.021. Epub 2019 Jan 23.

引用本文的文献

1
Changes in 10-Year Predicted Cardiovascular Disease Risk for a Multiethnic Semirural Population in South East Asia: Prospective Study.东南亚多民族半农村人群 10 年心血管疾病预测风险的变化:前瞻性研究。
JMIR Public Health Surveill. 2024 Sep 26;10:e55261. doi: 10.2196/55261.
2
The 30-year cardiovascular risk trajectories and their independently associated factors in participants of a Brazilian cohort (CUME Study).巴西队列研究(CUME 研究)中参与者的 30 年心血管风险轨迹及其独立相关因素。
Cad Saude Publica. 2023 Sep 25;39(9):e00041323. doi: 10.1590/0102-311XEN041323. eCollection 2023.
3
Trajectories of Lipid Profile and Risk of Carotid Atherosclerosis Progression: A Longitudinal Cohort Study.

本文引用的文献

1
Cardiovascular risk assessment in the 21st century.21世纪的心血管风险评估。
JAMA. 2012 Aug 22;308(8):816-7. doi: 10.1001/2012.jama.10456.
2
Is estimating lifetime cardiovascular risk useful?评估终生心血管风险有用吗?
BMJ. 2010 Dec 31;341:c7379. doi: 10.1136/bmj.c7379.
3
Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.基于 QResearch 数据库的队列研究:推导、验证和评估一种新的 QRISK 模型以估计心血管疾病终生风险
血脂谱轨迹与颈动脉粥样硬化进展风险:一项纵向队列研究。
Nutrients. 2022 Aug 8;14(15):3243. doi: 10.3390/nu14153243.
4
Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study.18 年随访期间心血管疾病风险轨迹及其与心血管事件发生率的关系:德黑兰血脂和血糖研究。
J Transl Med. 2021 Jul 16;19(1):309. doi: 10.1186/s12967-021-02984-2.
5
Association of Blood Pressure and Risk of Cardiovascular and Chronic Kidney Disease in Hong Kong Hypertensive Patients.香港高血压患者的血压与心血管和慢性肾脏疾病风险的关联。
Hypertension. 2019 Aug;74(2):331-340. doi: 10.1161/HYPERTENSIONAHA.119.13123. Epub 2019 Jun 24.
6
Changes in cardiovascular risk and clinical outcomes in a HIV/AIDS cohort study over a 1-year period at a specialized clinic in Mexico.在墨西哥一家专科诊所进行的一项为期1年的HIV/AIDS队列研究中,心血管风险和临床结局的变化。
Ther Clin Risk Manag. 2018 Sep 25;14:1757-1764. doi: 10.2147/TCRM.S170536. eCollection 2018.
7
The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study.重复血压测量用于心血管风险预测:ARIC研究中统计模型的比较
Stat Med. 2017 Dec 10;36(28):4514-4528. doi: 10.1002/sim.7144. Epub 2016 Oct 11.
BMJ. 2010 Dec 9;341:c6624. doi: 10.1136/bmj.c6624.
4
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2010年美国心脏病学会基金会/美国心脏协会无症状成年人心血管风险评估指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2010 Dec 21;122(25):e584-636. doi: 10.1161/CIR.0b013e3182051b4c. Epub 2010 Nov 15.
5
Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies.采用新的糖化血红蛋白诊断标准评估欧洲癌症前瞻性调查-诺福克队列人群 2 型糖尿病的发病率:对预防策略的影响。
Diabetes Care. 2011 Apr;34(4):950-6. doi: 10.2337/dc09-2326. Epub 2010 Jul 9.
6
Cardiovascular risk prediction: basic concepts, current status, and future directions.心血管风险预测:基本概念、现状与未来方向。
Circulation. 2010 Apr 20;121(15):1768-77. doi: 10.1161/CIRCULATIONAHA.109.849166.
7
Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.10年和终生冠心病风险信息在心血管预防用药决策中的潜在应用:一项初级保健医生调查
Arch Intern Med. 2010 Mar 8;170(5):470-7. doi: 10.1001/archinternmed.2009.525.
8
Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006.美国成年人心血管疾病10年和终生预测风险分布:2003年至2006年国家健康和营养检查调查结果
Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):8-14. doi: 10.1161/CIRCOUTCOMES.109.869727. Epub 2009 Nov 16.
9
Primary prevention of cardiovascular disease: time to get more or less personal?心血管疾病的一级预防:是时候或多或少地因人而异了吗?
JAMA. 2009 Nov 18;302(19):2144-5. doi: 10.1001/jama.2009.1698.
10
Cardiovascular risk assessment scores for people with diabetes: a systematic review.糖尿病患者的心血管风险评估分数:一项系统综述
Diabetologia. 2009 Oct;52(10):2001-14. doi: 10.1007/s00125-009-1454-0. Epub 2009 Jul 24.